InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,035.17
(
0.33%
)
US TECH 100
16,893.60
(
0.19%
)
Dow Jones
38,056.51
(
0.40%
)
Brent Oil
83.47
(
-0.09%
)
Bitcoin
58,667.97
(
0.74%
)
Post# of 251673
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119535
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Double_Bagel post# 209630

Sunday, 03/05/2017 7:06:22 PM

Sunday, March 05, 2017 7:06:22 PM

Post# of 251673
Re: MYL’s Copaxone ANDAs

Please see #msg-112812696, #msg-112817624, #msg-112848073, and #msg-112804827 for comments on this question. Also, bear in mind that the FDA has had MYL’s 20mg-Copaxone ANDA under review for 7.5 (!) years (#msg-41441618); if MYL truly understood how to replicate Copaxone, one would think they would have approval of the 20mg ANDA by now.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up